1. Redox signaling in drug-tolerant persister cells as an emerging therapeutic target
   Zhe Zhang et al, 2023, eBioMedicine CrossRef
2. POLR2J expression promotes glioblastoma malignancy by regulating oxidative stress and the STAT3 signaling pathway
   Xiao-Li Zheng, 2024, American Journal of Cancer Research CrossRef
3. The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells
   Sophia S. Borisevich et al, 2024, Cancers CrossRef
4. MicroRNA-221-3p inhibits the inflammatory response of keratinocytes by regulating the DYRK1A/STAT3 signaling pathway to promote wound healing in diabetes
   Keyan Hu et al, 2024, Communications Biology CrossRef
5. HIF‐1α regulates the cell viability in radioiodine‐resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF‐κB signaling pathway
   Dong Wang et al, 2024, Molecular Carcinogenesis CrossRef
6. Systems biology approach to identify biomarkers and therapeutic targets for colorectal cancer
   Niloufar Sadat Kalaki et al, 2024, Biochemistry and Biophysics Reports CrossRef
7. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway
   Xiaodong Li et al, 2023, Molecular and Cellular Probes CrossRef
8. Function and inhibition of DYRK1A: Emerging roles of treating multiple human diseases
   Yuping Yang et al, 2023, Biochemical Pharmacology CrossRef
9. An oncolytic system produces oxygen selectively in pancreatic tumor cells to alleviate hypoxia and improve immune activation
   Yu Chen et al, 2024, Pharmacological Research CrossRef
10. Harmine ameliorates steroid-induced osteonecrosis of the femoral head by modulating metabolism and ferroptosis via HIF1-α
    Wenming Li et al, 2023, Fundamental Research CrossRef